OPKO Health Q1 2024 GAAP EPS $(0.12) Misses $(0.10) Estimate, Sales $173.700M Miss $182.990M Estimate
Portfolio Pulse from Benzinga Newsdesk
OPKO Health (NASDAQ:OPK) reported Q1 2024 GAAP EPS of $(0.12), missing the $(0.10) estimate, and sales of $173.7M, below the $182.99M estimate. This represents a significant decrease from the previous year, with a 500% increase in losses per share and a 26.89% decrease in sales.
May 07, 2024 | 8:56 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
OPKO Health's Q1 2024 earnings and sales missed estimates, with a significant year-over-year decline in financial performance.
Missing both EPS and sales estimates, especially with such a significant year-over-year decline, is likely to negatively impact investor sentiment and the stock price in the short term. The magnitude of the miss and the comparison to last year's performance highlight underlying challenges the company may be facing.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100